National Health Investors (NHI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Core Insights - National Health Investors (NHI) reported revenue of $82.94 million for the quarter ended September 2024, reflecting a 3.5% increase year-over-year [1] - Earnings per share (EPS) for the quarter was$ 1.03, up from $0.68 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of$ 80.7 million by 2.78%, while the EPS fell short of the consensus estimate of $1.07 by 3.74% [1] Revenue Breakdown - Rental income was$ 63.32 million, surpassing the average estimate of $62.52 million, with a year-over-year increase of 1.7% [3] - Interest income and other revenues totaled$ 5.86 million, slightly above the estimated $5.81 million, marking a 6.8% increase from the previous year [3] - Resident fees and services generated$ 13.77 million, exceeding the estimate of $13.53 million, representing an 11.4% year-over-year growth [3] Stock Performance - Over the past month, shares of National Health Investors have declined by 6.1%, compared to a 0.5% decrease in the Zacks S&P 500 composite [4] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [4]